Center for Cancer Immunotherapy and Immunobiology

Why Research on Cancer Immunotherapy?
Research is a fundamental human endeavor and the sheer joy of a new discovery is a reward in itself. The letters and e-mails from patients below are a reminder of the tremendous impact that fundamental research undertaken at CCII can have on individual patients. Our efforts to improve cancer immunotherapy are continuing!

Letters & E-mails from Patients

Dear Dr. Tasuku Honjo

15th August 2019


Every morning I know my prospects would be very differebt without your efforts. I feel in love with life and want to keep living. I owe you a lot!

I am being treated with Opdivo and feel very hopeful about my life expectancy. Your dedication, intelligence and boldness allowed you to make breakthroughs. I will never know you personally, but say a prayer of thanksgiving to you.

Dear Dr. Tasuku Honjo

6th June 2022


I hope this e-mail reaches you. My name is […] .My wife is being treated with nivolumab for hepato-cellular carcinoma with some minimal portal vein invasion. She is doinig quite well considering that the oncology team at University of Pennsylvania warned us that HCC head low percentage rate of response. Her oncology team has been pleasantly surprised by her response!

Thank you and God bless you for all your initial work with nivolumab.

Most respectfully,
[…]

WordPress Lightbox